Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stem Cell Research

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 207 articles:
HTML format



Single Articles


    November 2021
  1. IMAHASHI N, Terakura S, Kondo E, Kato K, et al
    Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies.
    Bone Marrow Transplant. 2021 Nov 24. pii: 10.1038/s41409-021-01525.
    PubMed     Abstract available


  2. SHUMILOV E, Shakhanova I, Flach J, Schmidt N, et al
    Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Nov 13. pii: 10.1038/s41409-021-01521.
    PubMed     Abstract available


  3. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2021 Nov 12. pii: 10.1038/s41409-021-01523.
    PubMed    


  4. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2021 Nov 12. pii: 10.1038/s41409-021-01516.
    PubMed    


  5. OTTH M, Yammine S, Usemann J, Latzin P, et al
    Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Nov 8. pii: 10.1038/s41409-021-01509.
    PubMed     Abstract available


  6. SCHMID C, Labopin M, Schaap N, Veelken H, et al
    Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia.
    Bone Marrow Transplant. 2021 Nov 8. pii: 10.1038/s41409-021-01515.
    PubMed     Abstract available


  7. ALZAHRANI M, Damlaj M, Essa M, Alahmari B, et al
    HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome.
    Bone Marrow Transplant. 2021 Nov 6. pii: 10.1038/s41409-021-01513.
    PubMed    


  8. GARNICA M, Dalcolmo S, Gaio B, de Almeida AR, et al
    Pre-engraftment Cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation and its impact on engraftment.
    Bone Marrow Transplant. 2021 Nov 1. pii: 10.1038/s41409-021-01520.
    PubMed    


    October 2021
  9. MARTINO R, Garcia-Cadenas I, Esquirol A
    Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation.
    Bone Marrow Transplant. 2021 Oct 28. pii: 10.1038/s41409-021-01507.
    PubMed    


  10. MIKULSKA M, Penack O, Wendel L, Knelange N, et al
    HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
    Bone Marrow Transplant. 2021 Oct 23. pii: 10.1038/s41409-021-01497.
    PubMed     Abstract available


  11. MARTINO M, Pitino A, Gori M, Viens P, et al
    Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study.
    Bone Marrow Transplant. 2021 Oct 23. pii: 10.1038/s41409-021-01503.
    PubMed    


  12. TIEN FM, Tsai CH, Huang SC, Liu JH, et al
    Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission.
    Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01454.
    PubMed     Abstract available


  13. WANG X, Yu U, Yang C, Wang C, et al
    Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01499.
    PubMed    


  14. SMITH PJ, Lew M, Lowder Y, Romero K, et al
    Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 19. pii: 10.1038/s41409-021-01470.
    PubMed     Abstract available


  15. VO P, Onstad L, Flowers ME, Storb R, et al
    Cancers after HLA-matched related bone marrow transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Oct 16. pii: 10.1038/s41409-021-01498.
    PubMed     Abstract available


  16. CARTER M, Taniguchi M, Yang D, Arslan S, et al
    Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Oct 11. pii: 10.1038/s41409-021-01494.
    PubMed    


  17. SALVINI M, Maggi F, Damonte C, Mortara L, et al
    Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 11. pii: 10.1038/s41409-021-01487.
    PubMed    


  18. KOBAYASHI S, Kanda Y, Konuma T, Inamoto Y, et al
    Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation.
    Bone Marrow Transplant. 2021 Oct 8. pii: 10.1038/s41409-021-01485.
    PubMed     Abstract available


  19. SELLNER L, Schetelig J, Koster L, Choi G, et al
    Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.
    Bone Marrow Transplant. 2021 Oct 7. pii: 10.1038/s41409-021-01490.
    PubMed    


  20. SAVOIA C, McKeough N, Hickey B, Cochrane T, et al
    Comparison of a therapeutic platelet transfusion strategy to a prophylactic platelet transfusion strategy in autologous stem cell transplant (ASCT), a single centre experience.
    Bone Marrow Transplant. 2021 Oct 6. pii: 10.1038/s41409-021-01482.
    PubMed    


  21. MILLARD T, Sammour F, Anthias C, Easdale S, et al
    Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?
    Bone Marrow Transplant. 2021 Oct 5. pii: 10.1038/s41409-021-01484.
    PubMed    


  22. POIRE X, Graux C, Ory A, Herman J, et al
    Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective s
    Bone Marrow Transplant. 2021 Oct 5. pii: 10.1038/s41409-021-01464.
    PubMed    


  23. PERRUCCIO K, Menconi M, Galaverna F, Pagliara D, et al
    Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses.
    Bone Marrow Transplant. 2021 Oct 4. pii: 10.1038/s41409-021-01285.
    PubMed    


  24. NAKAMURA ZM, Heiling HM, Park EM, Deal AM, et al
    Impact of patient and clinical characteristics on cognitive changes after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 2. pii: 10.1038/s41409-021-01481.
    PubMed    


    September 2021
  25. MAMEZ AC, Pradier A, Giannotti F, Petitpas A, et al
    Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Sep 28. pii: 10.1038/s41409-021-01466.
    PubMed    


  26. PERIC Z, Peczynski C, Polge E, Kroger N, et al
    Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT.
    Bone Marrow Transplant. 2021 Sep 24. pii: 10.1038/s41409-021-01458.
    PubMed    


  27. YOKOYAMA H, Hirayama M, Takahashi Y, Uchida N, et al
    Altered effect of killer immunoglobulin-like receptor-ligand mismatch by graft versus host disease prophylaxis in cord blood transplantation.
    Bone Marrow Transplant. 2021 Sep 24. pii: 10.1038/s41409-021-01469.
    PubMed     Abstract available


  28. RAMOS TL, Garcia-Guerrero E, Caballero-Velazquez T, Rodriguez-Gil A, et al
    Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Sep 23. pii: 10.1038/s41409-021-01452.
    PubMed     Abstract available


  29. ROCHA V, Arcuri LJ, Seber A, Colturato V, et al
    Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia.
    Bone Marrow Transplant. 2021 Sep 21. pii: 10.1038/s41409-021-01453.
    PubMed     Abstract available


  30. HOUIST AL, Bondeelle L, Salmona M, LeGoff J, et al
    Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
    Bone Marrow Transplant. 2021 Sep 21. pii: 10.1038/s41409-021-01462.
    PubMed     Abstract available


  31. NIE D, Zhang J, Liu L, Li X, et al
    Targeted minor histocompatibility antigen typing to estimate graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 16. pii: 10.1038/s41409-021-01459.
    PubMed     Abstract available


  32. SCORTECHINI I, Inglese E, Saraceni F, Poiani M, et al
    Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature.
    Bone Marrow Transplant. 2021 Sep 16. pii: 10.1038/s41409-021-01361.
    PubMed    


  33. YAMAMOTO S, Kato M, Watanabe K, Ishimaru S, et al
    Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01446.
    PubMed     Abstract available


  34. ABUELGASIM KA, Damlaj M, Bosaeed M, Altamimi S, et al
    Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01457.
    PubMed    


  35. PINCEZ T, Santiago R, Bittencourt H, Louis I, et al
    Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children.
    Bone Marrow Transplant. 2021 Sep 2. pii: 10.1038/s41409-021-01408.
    PubMed     Abstract available


    August 2021
  36. DIAZ-DE-HEREDIA C, Bresters D, Faulkner L, Yesilipek A, et al
    Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.
    Bone Marrow Transplant. 2021 Aug 31. pii: 10.1038/s41409-021-01449.
    PubMed     Abstract available


  37. AKDOGAN N, Ersoy-Evans S, Visal Okur F, Kuskonmaz B, et al
    Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Aug 27. pii: 10.1038/s41409-021-01441.
    PubMed    


  38. MALLADI R, Ahmed I, McIlroy G, Dignan FL, et al
    Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial.
    Bone Marrow Transplant. 2021 Aug 26. pii: 10.1038/s41409-021-01439.
    PubMed     Abstract available


  39. XU LP, Lu PH, Wu DP, Sun ZM, et al
    Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01431.
    PubMed     Abstract available


  40. GOKLEMEZ S, Saligan LN, Pirsl F, Holtzman NG, et al
    Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01419.
    PubMed     Abstract available


  41. SNARSKI E, Stringer J, Mikulska M, Gil L, et al
    Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of
    Bone Marrow Transplant. 2021 Aug 21. pii: 10.1038/s41409-021-01430.
    PubMed     Abstract available


  42. JANSSEN MJM, Bruns AHW, Verduyn Lunel FM, Raijmakers RAP, et al
    Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 20. pii: 10.1038/s41409-021-01437.
    PubMed     Abstract available


  43. MODEMANN F, Ayuk F, Wolschke C, Christopeit M, et al
    Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01425.
    PubMed    


  44. WOLFF D, Herzberg PY, Herrmann A, Pavletic SZ, et al
    Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of H
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01404.
    PubMed    


  45. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01405.
    PubMed    


  46. GRANELL M, Senin A, Barata A, Cibeira MT, et al
    Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2021 Aug 17. pii: 10.1038/s41409-021-01429.
    PubMed     Abstract available


  47. JAYANI RV, Olin RL
    Physically "fit" for allogeneic stem cell transplant?
    Bone Marrow Transplant. 2021 Aug 16. pii: 10.1038/s41409-021-01436.
    PubMed    


  48. TAMAI H, Tajika K, Nakayama K, Arai A, et al
    Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide.
    Bone Marrow Transplant. 2021 Aug 12. pii: 10.1038/s41409-021-01432.
    PubMed    


  49. MISHRA A, Pidala J, Thapa R, Betts BC, et al
    Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01428.
    PubMed     Abstract available


  50. OHMOTO A, Fuji S
    Cardiac complications associated with hematopoietic stem-cell transplantation.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01427.
    PubMed     Abstract available


  51. WU Y, Zhao Y, Wang T, Xia J, et al
    Evaluation of diagnostic performance of metagenomic next-generation sequencing when applied in patients after allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2021 Aug 10. pii: 10.1038/s41409-021-01423.
    PubMed    


  52. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Aug 9. pii: 10.1038/s41409-021-01421.
    PubMed    


  53. CORNILLON J, Daguenet E, Tournilhac O, Blaise D, et al
    Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire.
    Bone Marrow Transplant. 2021 Aug 6. pii: 10.1038/s41409-021-01426.
    PubMed     Abstract available


    July 2021
  54. NIEDERWIESER C, Morozova E, Zubarovskaya L, Zabelina T, et al
    Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
    Bone Marrow Transplant. 2021 Jul 30. pii: 10.1038/s41409-021-01410.
    PubMed     Abstract available


  55. LEW TE, Cliff ERS, Dickinson M, Tam CS, et al
    T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.
    Bone Marrow Transplant. 2021 Jul 20. pii: 10.1038/s41409-021-01418.
    PubMed    


  56. KANG HM, Kim SK, Ryu IH, Lee JW, et al
    Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
    PubMed     Abstract available


  57. ZUCENKA A, Vaitekenaite V, Maneikis K, Davainis L, et al
    Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01416.
    PubMed     Abstract available


  58. ABO S, Ritchie D, Denehy L, Panek-Hudson Y, et al
    Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study.
    Bone Marrow Transplant. 2021 Jul 16. pii: 10.1038/s41409-021-01411.
    PubMed     Abstract available


  59. JENTZSCH M, Grimm J, Bill M, Kupper J, et al
    Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01407.
    PubMed    


  60. KONDO G, Ishimaru F, Konuma T, Takahashi S, et al
    Cord blood index predicts engraftment and early non-relapse mortality in adult patients with single-unit cord blood transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01406.
    PubMed     Abstract available


  61. CUVELIER S, Blaise D, Boher JM, Villaron-Goetgheluck C, et al
    A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 14. pii: 10.1038/s41409-021-01401.
    PubMed     Abstract available


  62. LUFT T, Dreger P, Radujkovic A
    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01390.
    PubMed     Abstract available


  63. ALARCON TOMAS A, Whiting K, Maloy M, Ruiz JD, et al
    The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01392.
    PubMed     Abstract available


  64. BORTNICK R, Wlodarski M, de Haas V, De Moerloose B, et al
    Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Jul 9. pii: 10.1038/s41409-021-01374.
    PubMed     Abstract available


  65. TANG FF, Zhao XY, Huo MR, Chang YJ, et al
    Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.
    Bone Marrow Transplant. 2021 Jul 8. pii: 10.1038/s41409-021-01382.
    PubMed     Abstract available


  66. COSTA TCM, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, et al
    Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01365.
    PubMed     Abstract available


  67. LANKESTER AC, Albert MH, Booth C, Gennery AR, et al
    EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01378.
    PubMed    


  68. BAA AK, Chellapuram SK, Sharma A, Malik PS, et al
    Poems syndrome: consolidation with autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01395.
    PubMed    


  69. PRYCE A, Mir F, Ushiro-Lumb I, Drypen R, et al
    SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01379.
    PubMed    


  70. LIU L, Miao M, Chen X, Zhang Y, et al
    Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01398.
    PubMed    


  71. WOLFF D, Fatobene G, Rocha V, Kroger N, et al
    Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01389.
    PubMed     Abstract available


  72. ANSARI M, Petrykey K, Rezgui MA, Del Vecchio V, et al
    Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT.
    Bone Marrow Transplant. 2021 Jul 2. pii: 10.1038/s41409-021-01386.
    PubMed     Abstract available


  73. LUCIA A, Fiuza-Luces C
    Physical fitness and childhood hematopoietic stem cell transplantation: a call to action.
    Bone Marrow Transplant. 2021 Jul 1. pii: 10.1038/s41409-021-01397.
    PubMed    


    June 2021
  74. LUPO-STANGHELLINI MT, Xue E, Mastaglio S, Oltolini C, et al
    COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
    Bone Marrow Transplant. 2021 Jun 30. pii: 10.1038/s41409-021-01278.
    PubMed    


  75. LEMIEUX C, Muffly LS, Iberri DJ, Craig JK, et al
    Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
    Bone Marrow Transplant. 2021 Jun 23. pii: 10.1038/s41409-021-01371.
    PubMed     Abstract available


  76. GILFANOVA R, Callegari A, Childs A, Yang G, et al
    A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01368.
    PubMed     Abstract available


  77. FRIDH MK, Simonsen C, Schmidt-Andersen P, Nissen AA, et al
    Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01370.
    PubMed     Abstract available


  78. BERGERON A
    Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions!
    Bone Marrow Transplant. 2021 Jun 18. pii: 10.1038/s41409-021-01381.
    PubMed    


  79. FERNANDEZ-SOJO J, Azqueta C, Valdivia E, Martorell L, et al
    Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
    Bone Marrow Transplant. 2021 Jun 14. pii: 10.1038/s41409-021-01367.
    PubMed     Abstract available


  80. BONIFAZI F, Defrancesco I, Olivieri J, Barbato F, et al
    Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01359.
    PubMed    


  81. FLOISAND Y, Schroeder MA, Chevallier P, Selleslag D, et al
    A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01356.
    PubMed     Abstract available


  82. KAWASHIMA N, Nishikawa E, Tsuchisaka A, Hashimoto T, et al
    Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01335.
    PubMed    


    May 2021
  83. ESQUIROL A, Pascual MJ, Kwon M, Perez A, et al
    Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01328.
    PubMed     Abstract available


  84. WAIDHAUSER J, Labopin M, Esteve J, Kroger N, et al
    Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01322.
    PubMed     Abstract available


  85. KUMARI R, Palaniyandi S, Hildebrandt GC
    The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease.
    Bone Marrow Transplant. 2021 May 29. pii: 10.1038/s41409-021-01325.
    PubMed    


  86. SUN X, Yang J, Cai Y, Wan L, et al
    Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation
    Bone Marrow Transplant. 2021 May 25. pii: 10.1038/s41409-021-01358.
    PubMed     Abstract available


  87. GRECO R, Alexander T, Burman J, Del Papa N, et al
    Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01326.
    PubMed     Abstract available


  88. LACY M, Fong M, Bolton C, Maranzano M, et al
    Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01331.
    PubMed     Abstract available


  89. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
    T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
    PubMed     Abstract available


  90. MIKULSKA M, Tridello G, Hoek J, Gil L, et al
    Legionellosis after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 22. pii: 10.1038/s41409-021-01333.
    PubMed     Abstract available


  91. BEAUVERD Y, Morin S, Stephan C, De Ramon Ortiz C, et al
    The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
    Bone Marrow Transplant. 2021 May 18. pii: 10.1038/s41409-021-01334.
    PubMed    


  92. SHIMOMURA Y, Hara M, Konuma T, Itonaga H, et al
    Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients.
    Bone Marrow Transplant. 2021 May 15. pii: 10.1038/s41409-021-01324.
    PubMed     Abstract available


  93. SEO S, Usui Y, Matsuo K, Atsuta Y, et al
    Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2021 May 14. pii: 10.1038/s41409-021-01289.
    PubMed     Abstract available


  94. VIJENTHIRA A, Kuruvilla J, Prica A
    Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01327.
    PubMed     Abstract available


  95. XU L, Feng J, Xu X, Li X, et al
    IL-17-producing gammadeltaT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1(+)CD11b(+) myeloid-derived suppressor cells.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01299.
    PubMed     Abstract available


  96. MURATA M, Terakura S, Wake A, Miyao K, et al
    Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence.
    Bone Marrow Transplant. 2021 May 11. pii: 10.1038/s41409-021-01304.
    PubMed     Abstract available


  97. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 10. pii: 10.1038/s41409-021-01315.
    PubMed    


  98. ALBERT MH, Sirin M, Hoenig M, Hauck F, et al
    Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
    Bone Marrow Transplant. 2021 May 9. pii: 10.1038/s41409-021-01323.
    PubMed     Abstract available


  99. DE OLIVEIRA RODRIGUES M, de Almeida Testa LH, Dos Santos ACF, Zanetti LP, et al
    Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 8. pii: 10.1038/s41409-021-01329.
    PubMed     Abstract available


  100. SHIRATORI S, Sugita J, Fuji S, Aoki J, et al
    Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01314.
    PubMed     Abstract available


  101. DERENZINI E, Tabanelli V, Sammassimo S, Mazzara S, et al
    Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01320.
    PubMed    


  102. FRIEDMAN D, Dozor AJ, Milner J, D'Souza M, et al
    Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2021 May 6. pii: 10.1038/s41409-021-01298.
    PubMed     Abstract available


  103. KALOYANNIDIS P, Ayyad A, Bahaliwah Z, Blowi B, et al
    Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01318.
    PubMed    


  104. DE LA PUERTA R, Montoro J, Aznar C, Lorenzo I, et al
    Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01319.
    PubMed     Abstract available


  105. OOSTENBRINK LVE, Pool ES, Jol-van der Zijde CM, Jansen-Hoogendijk AM, et al
    Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 3. pii: 10.1038/s41409-021-01302.
    PubMed     Abstract available


    April 2021
  106. TOYODA K, Yasunaga JI, Choi I, Suehiro Y, et al
    The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01311.
    PubMed    


  107. HARADA K, Kimura SI, Fuji S, Najima Y, et al
    Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01310.
    PubMed     Abstract available


  108. SAITO Y, Urashima M, Takahashi Y, Ogawa A, et al
    Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01303.
    PubMed     Abstract available


  109. BURT RK, Muraro PA, Farge D, Oliveira MC, et al
    New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01277.
    PubMed     Abstract available


  110. RAGON BK
    FLT3-ITDos and FLT3-ITDon'ts: navigating maintenance therapy in FLT3-ITD-positive acute myeloid leukemia following stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01269.
    PubMed    


  111. AMONOO HL, El-Jawahri A, Celano CM, Brown LA, et al
    A positive psychology intervention to promote health outcomes in hematopoietic stem cell transplantation: the PATH proof-of-concept trial.
    Bone Marrow Transplant. 2021 Apr 20. pii: 10.1038/s41409-021-01296.
    PubMed     Abstract available


  112. INOUE Y, Okinaka K, Fuji S, Inamoto Y, et al
    Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01291.
    PubMed     Abstract available


  113. FIALA MA, King J, Feinberg D, Goldsmith SR, et al
    Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01295.
    PubMed    


  114. RUSSO D, Polverelli N, Malagola M, Farina M, et al
    Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01287.
    PubMed     Abstract available


  115. EYRE TA, Caillard S, Finel H, Boumendil A, et al
    Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2021 Apr 16. pii: 10.1038/s41409-021-01270.
    PubMed     Abstract available


  116. RAMDIAL JL, Mehta RS, Saliba RM, Alousi AM, et al
    Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01274.
    PubMed     Abstract available


  117. WU J, Fu HX, He Y, Mo XD, et al
    Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01293.
    PubMed     Abstract available


  118. EGLSEER D, Bauer S, Huber-Krassnitzer B, Greinix H, et al
    Malnutrition risk prior to hematopoietic stem cell transplantation predicts mortality in adults.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01292.
    PubMed     Abstract available


  119. NELSON AM, Johnson PC, Kavanaugh AR, Jackson VA, et al
    Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01281.
    PubMed     Abstract available


  120. BADAR T, Szabo A, Litzow M, Burkart M, et al
    Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01279.
    PubMed     Abstract available


  121. LIU W, Fan Z, Zhang Y, Huang F, et al
    Metagenomic next-generation sequencing for identifying pathogens in central nervous system complications after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01243.
    PubMed     Abstract available


  122. HAGHIRI S, Fayech C, Mansouri I, Dufour C, et al
    Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01258.
    PubMed     Abstract available


  123. STATHOPOULOS P, Leger K, Foege M, Lutterotti A, et al
    Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01276.
    PubMed    


    March 2021
  124. DAHER-REYES G, Kim T, Novitzky-Basso I, Kim KH, et al
    Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01255.
    PubMed     Abstract available


  125. BENTO L, Gutierrez A, Novelli S, Montoro J, et al
    Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01264.
    PubMed     Abstract available


  126. LAZZARO C, Castagna L, Lanza F, Laszlo D, et al
    Chemotherapy-based versus chemotherapy-free stem cell mobilization (+/- plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis.
    Bone Marrow Transplant. 2021 Mar 22. pii: 10.1038/s41409-021-01251.
    PubMed     Abstract available


  127. IMOTO H, Yoshioka S, Hiramoto N, Morita-Fujita M, et al
    Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.
    Bone Marrow Transplant. 2021 Mar 10. pii: 10.1038/s41409-021-01263.
    PubMed    


  128. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01254.
    PubMed     Abstract available


  129. KONISHI T, Kusakabe S, Hino A, Inamoto K, et al
    Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01249.
    PubMed    


  130. KAPOOR J, Khushoo V, Garg A, Naim F, et al
    An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01256.
    PubMed    


  131. SHAH RM
    Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01246.
    PubMed     Abstract available


  132. RUGGERI A, Labopin M, Angelucci E, Blaise D, et al
    Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01248.
    PubMed     Abstract available


  133. RITACCO C, Ehx G, Gregoire C, Daulne C, et al
    High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 4. pii: 10.1038/s41409-021-01221.
    PubMed     Abstract available


  134. REUSING SB, Manser AR, Groeneveld-Krentz S, Rebmann V, et al
    HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01231.
    PubMed    


  135. ELMARIAH H, Naqvi SMH, Kim J, Nishihori T, et al
    Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01219.
    PubMed     Abstract available


  136. SHIMOMURA Y, Hara M, Yamamoto H, Uchida N, et al
    Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01217.
    PubMed     Abstract available


  137. PULIAFITO B, Zhao Y, Afshar S, Galitzeck Z, et al
    Comparison of post-transplant vaccination among allogeneic and autologous hematopoietic stem cell transplant patients: a single center quality analysis.
    Bone Marrow Transplant. 2021 Mar 1. pii: 10.1038/s41409-021-01240.
    PubMed    


    February 2021
  138. TANG X, Valdez BC, Ma Y, Zhang Q, et al
    Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01238.
    PubMed     Abstract available


  139. MISKIEWICZ-BUJNA J, Miskiewicz-Migon I, Panasiuk A, Kubica-Cielinska A, et al
    Severe and fatal toxicity after hematopoietic stem cell transplantation in GNE defect-associated thrombocytopenia.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01235.
    PubMed    


  140. LAI X, Liu L, Zhang Z, Shi L, et al
    Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Bone Marrow Transplant. 2021 Feb 19. pii: 10.1038/s41409-021-01233.
    PubMed     Abstract available


  141. CHRISTOPEIT M, Reichard M, Niederwieser C, Massoud R, et al
    Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01225.
    PubMed    


  142. SHEIKH MA, Im A, Ballen K, Hashmi SK, et al
    Association of graft-versus-host-disease with neurologic complications: clinical paradigm and future directions.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01216.
    PubMed    


  143. PAUTAS C, Raffoux E, Lambert J, Legrand O, et al
    Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-020-01207.
    PubMed     Abstract available


  144. RUBEN CL, Pirsl F, Steinberg SM, Holtzman NG, et al
    Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-021-01211.
    PubMed     Abstract available


  145. PRINCE HM, Abeyakoon C
    Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sezary syndrome: never-late, never-never?
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-020-01150.
    PubMed    


    January 2021
  146. DAI H, Penack O, Radujkovic A, Schult D, et al
    Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
    Bone Marrow Transplant. 2021 Jan 30. pii: 10.1038/s41409-020-01186.
    PubMed     Abstract available


  147. AHMED N, Li L, Rojas P, Covut F, et al
    Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01223.
    PubMed    


  148. SAKURAI M, Mori T, Kato K, Kanaya M, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01192.
    PubMed    


  149. CESARO S, Tridello G, Knelange NS, Blijlevens N, et al
    Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01212.
    PubMed     Abstract available


  150. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01200.
    PubMed     Abstract available


  151. LOPEZ R, Plat G, Bertrand Y, Ducassou S, et al
    Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study.
    Bone Marrow Transplant. 2021 Jan 16. pii: 10.1038/s41409-020-01180.
    PubMed     Abstract available


  152. VAN LEEUWEN SJM, Proctor GB, Laheij AMGA, Potting CMJ, et al
    Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01185.
    PubMed     Abstract available


  153. WEI N, Wang Y, Wang J, Wu L, et al
    Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01193.
    PubMed    


  154. DOMINGO-DOMENECH E, Duarte RF, Boumedil A, Onida F, et al
    Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sezary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01197.
    PubMed     Abstract available


  155. WALLACE G, Khandelwal P, Myers KC, Perentesis EMR, et al
    Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01189.
    PubMed     Abstract available


  156. OKOEV G, Weisdorf DJ, Wagner JE, Blazar BR, et al
    Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01195.
    PubMed     Abstract available


  157. SUN X, Su Y, Liu X, Zhang Y, et al
    Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models.
    Bone Marrow Transplant. 2021 Jan 7. pii: 10.1038/s41409-020-01187.
    PubMed     Abstract available


    December 2020
  158. GIAMMARCO S, Raiola AM, Di Grazia C, Bregante S, et al
    Second haploidentical stem cell transplantation for primary graft failure.
    Bone Marrow Transplant. 2020 Dec 16. pii: 10.1038/s41409-020-01183.
    PubMed     Abstract available


  159. XU ZL, Huang XJ
    Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01169.
    PubMed     Abstract available


  160. SANZ J, Labopin M, Sanz MA, Aljurf M, et al
    Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01162.
    PubMed     Abstract available


  161. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
    Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
    PubMed     Abstract available


  162. MORI T, Kikuchi T, Koh M, Koda Y, et al
    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
    PubMed     Abstract available


  163. MONTORO J, Chorao P, Bento L, Cabrero M, et al
    Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01161.
    PubMed    


  164. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    PubMed     Abstract available


  165. HIRSCHBUHL K, Labopin M, Houhou M, Gabellier L, et al
    Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2020 Dec 9. pii: 10.1038/s41409-020-01173.
    PubMed     Abstract available


  166. MAZIARZ RT, Levis M, Patnaik MM, Scott BL, et al
    Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
    Bone Marrow Transplant. 2020 Dec 7. pii: 10.1038/s41409-020-01153.
    PubMed     Abstract available


  167. BAKER LX, Chen F, Ssempijja Y, Byrne M, et al
    Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Dec 5. pii: 10.1038/s41409-020-01158.
    PubMed    


  168. SONG GY, Yoon DH, Suh C, Moon JH, et al
    Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01160.
    PubMed     Abstract available


  169. BAI B, Wang XX, Gao Y, Li PF, et al
    Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01164.
    PubMed     Abstract available


  170. VAXMAN I, Visram A, Kumar S, Dispenzieri A, et al
    Autologous stem cell transplantation for multiple myeloma patients aged >/= 75 treated with novel agents.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01159.
    PubMed     Abstract available


  171. JABBOUR J, Manana B, Zahreddine A, Al-Shaar L, et al
    Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial.
    Bone Marrow Transplant. 2020 Dec 1. pii: 10.1038/s41409-020-01154.
    PubMed     Abstract available


    November 2020
  172. BERRO M, Rivas M, Trucco J, Paganini I, et al
    Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center exper
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01146.
    PubMed    


  173. PAVIGLIANITI A, Labopin M, Blaise D, Socie G, et al
    Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01155.
    PubMed     Abstract available


  174. OTTH M, Schindera C, Gungor T, Ansari M, et al
    Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study.
    Bone Marrow Transplant. 2020 Nov 25. pii: 10.1038/s41409-020-01137.
    PubMed     Abstract available


  175. HUA J, Zhang J, Zhang X, Wu X, et al
    Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 24. pii: 10.1038/s41409-020-01140.
    PubMed     Abstract available


  176. EBBESEN M, Weischendorff S, Kielsen K, Kammersgaard M, et al
    Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01127.
    PubMed     Abstract available


  177. MENGLING T, Rall G, Bernas SN, Astreou N, et al
    Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01138.
    PubMed     Abstract available


  178. JENTZSCH M, Grimm J, Bill M, Brauer D, et al
    ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 19. pii: 10.1038/s41409-020-01129.
    PubMed     Abstract available


  179. VAXMAN I, Sidiqi MH, Al Saleh AS, Kumar S, et al
    Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.
    Bone Marrow Transplant. 2020 Nov 18. pii: 10.1038/s41409-020-01136.
    PubMed     Abstract available


  180. BLAGOV S, Zvyagin IV, Shelikhova L, Khismatullina R, et al
    T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after alphabeta T cell-depleted hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01128.
    PubMed     Abstract available


  181. MAAS-BAUER K, Kiote-Schmidt C, Bertz H, Apostolova P, et al
    Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01122.
    PubMed     Abstract available


  182. KANG HM, Kim SK, Lee JW, Chung NG, et al
    Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01121.
    PubMed     Abstract available


  183. CASTAGNA L, Pagliardini T, Bramanti S, Schiano de Colella JM, et al
    Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
    Bone Marrow Transplant. 2020 Nov 15. pii: 10.1038/s41409-020-01133.
    PubMed     Abstract available


  184. MARCO-AYALA J, Gomez-Segui I, Sanz G, Solves P, et al
    Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
    Bone Marrow Transplant. 2020 Nov 14. pii: 10.1038/s41409-020-01124.
    PubMed     Abstract available


  185. KHAN M, Iftikhar R, Ghafoor T, Hussain F, et al
    Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan.
    Bone Marrow Transplant. 2020 Nov 12. pii: 10.1038/s41409-020-01126.
    PubMed     Abstract available


  186. GERTZ MA, Lacy MQ, Jacob EK, Hogan WJ, et al
    Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2020 Nov 11. pii: 10.1038/s41409-020-01131.
    PubMed    


  187. SULTAN AM, Mahmoud HK, Fathy GM, Abdelfattah NM, et al
    The outcome of hematopoietic stem cell transplantation patients with COVID-19 infection.
    Bone Marrow Transplant. 2020 Nov 4. pii: 10.1038/s41409-020-01094.
    PubMed    


  188. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress.
    Bone Marrow Transplant. 2020 Nov 3. pii: 10.1038/s41409-020-01098.
    PubMed     Abstract available


  189. MORITA K, Fujiwara SI, Ikeda T, Kawaguchi SI, et al
    Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01096.
    PubMed     Abstract available


    October 2020
  190. IWAMOTO M, Ikegawa S, Kondo T, Meguri Y, et al
    Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01100.
    PubMed    


  191. YOON JH, Min GJ, Park SS, Park S, et al
    Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01097.
    PubMed     Abstract available


  192. IRENE GC, Albert E, Anna BV, Rahinatu A, et al
    Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching.
    Bone Marrow Transplant. 2020 Oct 26. pii: 10.1038/s41409-020-01092.
    PubMed     Abstract available


  193. EL-SERAFI A, He R, Zheng W, Benkossou F, et al
    Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.
    Bone Marrow Transplant. 2020 Oct 21. pii: 10.1038/s41409-020-01091.
    PubMed     Abstract available


  194. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 20. pii: 10.1038/s41409-020-01090.
    PubMed     Abstract available


  195. MODI D, Kim S, Deol A, Ayash L, et al
    Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Oct 16. pii: 10.1038/s41409-020-01079.
    PubMed     Abstract available


  196. BENTO L, Boumendil A, Finel H, Khvedelidze I, et al
    Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01075.
    PubMed     Abstract available


  197. KEKRE N, Kim HT, Hofer J, Ho VT, et al
    Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01083.
    PubMed     Abstract available


  198. MORISHIMA S, Fukuda T, Doki N, Mori T, et al
    Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
    Bone Marrow Transplant. 2020 Oct 9. pii: 10.1038/s41409-020-01070.
    PubMed     Abstract available


  199. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2020 Oct 7. pii: 10.1038/s41409-020-01053.
    PubMed     Abstract available


  200. LOKE J, Labopin M, Craddock C, Niederwieser D, et al
    Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01072.
    PubMed     Abstract available


  201. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01069.
    PubMed     Abstract available


    September 2020
  202. SUGITA J, Kamimura T, Ishikawa T, Ota S, et al
    Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Sep 24. pii: 10.1038/s41409-020-01065.
    PubMed     Abstract available


  203. MAAKARON JE, McKenna D Jr, El-Jurdi N, Arora M, et al
    COVID19 seroconversion in an unrelated stem cell donor.
    Bone Marrow Transplant. 2020 Sep 22. pii: 10.1038/s41409-020-01066.
    PubMed    


  204. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01056.
    PubMed     Abstract available


  205. SALEH W, Katz J
    Periodontal diseases, caries, and dental abscesses prevalence in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01057.
    PubMed    


    May 2020
  206. OLRY DE LABRY LIMA A, Matas Hoces A, Gimeno Ballester V, Rios Sanchez E, et al
    Cost-effectiveness of lenalidomide.
    Bone Marrow Transplant. 2020;55:853-854.
    PubMed    


  207. DHANASIRI S
    Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells.
    Bone Marrow Transplant. 2020;55:987-988.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: